Monoklonální protilátky

  • Analysis of Antibody Drug Conjugates Using SEC and Mass Spectrometry
    pdf, 571.93 KB
  • Analysis of Monoclonal Antibody (mAb) Using Agilent 1290 Infinity LC System Coupled to Agilent 6530 Accurate-Mass Quadrupole Time-of-Flight (Q-TOF)
    pdf, 751.41 KB
  • Analysis of Monoclonal Antibody Digests with the Agilent 1290 Infinity 2D-LC Solution - Part 2: HILIC × RPLC-MS
    pdf, 1.52 MB
  • Clone Selection Using the Agilent 1290 Infinity Online 2D-LC/MS Solution
    pdf, 2.75 MB
  • Drug-to-Antibody Ratio (DAR) Calculation of Antibody-Drug Conjugates (ADCs)
    pdf, 4.03 MB
  • Fast and Efficient Peptide Mapping of a Monoclonal Antibody (mAb): UHPLC Performance with Superficially Porous Particles
    pdf, 1.93 MB
  • LC/MS Analysis of Intact Therapeutic Monoclonal Antibodies Using AdvanceBio RP-mAb
    pdf, 1.15 MB
  • Analysis of Monoclonal Antibody (mAb) Using Agilent 1290 Infinity LC System Coupled to Agilent 6530 Accurate-Mass Quadrupole Time-of-Flight (Q-TOF)
    pdf, 751.41 KB
  • High Resolution and Rapid Peptide Mapping of Monoclonal Antibody Using an Agilent 1290 Infinity UHPLC and an Agilent 6550 iFunnel Q-TOF LC/MS System
    pdf, 1.26 MB
  • Analysis of Antibody Drug Conjugate Through Characterization of Drug Antibody Ratios
    pdf, 4.3 MB
  • High Resolution and Rapid Peptide Mapping of Monoclonal Antibody Using an Agilent 1290 Infinity UHPLC and an Agilent 6550 iFunnel Q-TOF LC/MS System
    pdf, 1.26 MB
  • Mapping the Drug Conjugation Sites of an Antibody-Drug Conjugate Using Automated Sample Preparation and LC/MS Analysis
    pdf, 549.42 KB
  • Peptide Mapping of Innovator and Biosimilar Monoclonal Antibody
    pdf, 842.26 KB
  • Analysis of Aggregates and Degradants of mAb and Antibody Drug Conjugate Using Size Exclusion 300Å, 2.7µm Column With an Aqueous Mobile Phase
    pdf, 759.62 KB
  • Bio-Monolith Protein G column - More Options for mAb Titer Determination
    pdf, 708.97 KB
  • Biomolecule Characterization workflow. Agilent Bio-Monolith Protein A and G Affinity columns
    pdf, 760.67 KB
  • Characterization of Intact Monoclonal Antibodies (mAb) and their fragments using Novel Reversed Phase Columns
    pdf, 1.26 MB
  • Quantitation of mAb and ADC Aggregation Using SEC and an Aqueous Mobile Phase
    pdf, 390.55 KB
  • Reversed-phase LC primary structure characterization workflow
    pdf, 1009.95 KB
  • Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC
    pdf, 302.66 KB
  • Size exclusion chromatography workflow with Agilent Bio-SEC columns and Agilent 1260 Bio-Inert LC systém
    pdf, 951.81 KB
  • Size exclusion chromatography with Agilent BioSec columns and Agilent 1260 Infinity Bio-Inert LC systém
    pdf, 762.98 KB